Andrew L. Schilb

Andrew L. Schilb

Auto-generated profile, based on publicly available information

Andrew L. Schilb

Department of Biomedical Engineering, School of Engineering, Case Western Reserve University, Cleveland, OH 44106, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ASAndrew L. Schilb
Andrew L. Schilb
JSJosef Scheidt
Josef Scheidt
AVAmita Vaidya
Amita Vaidya
ZSZhanhu Sun
Zhanhu Sun
DSDa Sun
Da Sun
Zheng-Rong LuZheng-Rong Lu
Zheng-Rong Lu
Nucleic acids are promising for a variety of therapies, such as cancer therapy and the gene therapy of genetic disorders. The therapeutic efficacy of nucleic acids is reliant on the ability of their efficient delivery to the cytosol of the target cells. Amino lipids have been developed to aid in the cytosolic delivery of nucleic acids. This work reports a new and efficient synthetic pathway for the lipid carrier, (1-aminoethyl) iminobis [N-(oleicylcysteinyl-1-amino-ethyl)propionamide] (ECO). The previous synthesis of the ECO was inefficient and presented poor product quality control. A solution-phase synthesis of the ECO was explored, and each intermediate product was characterized with better quality control. The ECO was synthesized with a relatively high yield and high purity. The formulations of the ECO nanoparticles were made with siRNA, miRNA, or plasmid DNA, and characterized. The transfection efficiency of the nanoparticles was evaluated in vitro over a range of N/P ratios. The nanoparticles were consistent in size with previous formulations and had primarily a positive zeta potential. The ECO/siLuc nanoparticles resulted in potent luciferase silencing with minimal cytotoxicity. The ECO/miR-200c nanoparticles mediated the efficient delivery of miR-200c into the target cells. The ECO/pCMV-GFP nanoparticles resulted in substantial GFP expression upon transfection. These results demonstrate that the solution-phase synthetic pathway produced pure ECO for the efficient intracellular delivery of nucleic acids without size limitation.

22 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ASAndrew L. Schilb
Andrew L. Schilb
JSJosef Scheidt
Josef Scheidt
AVAmita Vaidya
Amita Vaidya
ZSZhanhu Sun
Zhanhu Sun
DSDa Sun
Da Sun
Zheng-Rong LuZheng-Rong Lu
Zheng-Rong Lu
There was an error in the original publication